Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

Irene Lambrinoudaki¹, Eleni Armeni², Dimitrios Goulis³, Silvia Bretz⁴, Iuliana Ceausu⁵, Fatih Durmusoglu⁶, Risto Erkkola⁷, Ivan Fistonic⁸, Marco Gambacciani⁹, Marije Geukes¹⁰, Haitham Hamoda¹¹, Caiomhe Hartley¹², Angelica Lindén Hirschberg¹³, Blazej Meczekalski¹⁴, Nicolas Mendoza¹⁵, Alfred Mueck¹⁶, Antonina Smetnik¹⁷, Petra Stute¹⁸, Mick van Trotsenburg¹⁹, Margaret Rees²⁰

Affiliations

¹ Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece. Electronic address: ilambrinoudaki@med.uoa.gr.
² Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece.
³ Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece.
⁴ Clinica Silvia Bretz, Rio de Janeiro, Brazil.
⁵ Department of Obstetrics and Gynecology I, "Carol Davila" University of Medicine and Pharmacy, "Dr. I. Cantacuzino" Clinical Hospital, Bucharest, Romania.
⁶ Istanbul Medipol International School of Medicine, Istanbul, Turkey.
⁷ Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.
⁸ Institute for Women's Health, Zagreb, Croatia.
⁹ Menopause and Osteoporosis Unit, San Rossore Clinical Center, Pisa, Italy.
¹⁰ Department of Obstetrics and Gynecology, Ziekenhuisgroep Twente (Hospital Group Twente), Post Box 7600, 7600 SZ Almelo, the Netherlands.
¹¹ Department Gynaecology, King's College Hospital, Denmark Hill, London SE5 9RS, UK.
¹² Menopause Health Clinic, Dublin, Ireland.
¹³ Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
¹⁴ Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland.
¹⁵ Department of Obstetrics and Gynecology, University of Granada, Spain.
¹⁶ Department of Women's Health, University Hospital Tuebingen, Germany; Beijing OB/GYN Hospital, Capital Medical University, China.
¹⁷ Department of Gynecological Endocrinology, National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of the Russian Federation, Moscow, Russia.
¹⁸ Department of Obstetrics and Gynecology, University Clinic Inselspital, Bern, Switzerland.
¹⁹ Department of Obstetrics and Gynecology, University Hospital St. Poelten-Lilienfeld, Austria.
²⁰ Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.

PMID: 35569270
DOI: 10.1016/j.maturitas.2022.04.008

Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

Irene Lambrinoudaki et al. Maturitas. 2022 Sep.

. 2022 Sep:163:1-14.

doi: 10.1016/j.maturitas.2022.04.008. Epub 2022 May 12.

Authors

Affiliations

¹ Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece. Electronic address: ilambrinoudaki@med.uoa.gr.
² Second Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Greece.
³ Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece.
⁴ Clinica Silvia Bretz, Rio de Janeiro, Brazil.
⁵ Department of Obstetrics and Gynecology I, "Carol Davila" University of Medicine and Pharmacy, "Dr. I. Cantacuzino" Clinical Hospital, Bucharest, Romania.
⁶ Istanbul Medipol International School of Medicine, Istanbul, Turkey.
⁷ Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.
⁸ Institute for Women's Health, Zagreb, Croatia.
⁹ Menopause and Osteoporosis Unit, San Rossore Clinical Center, Pisa, Italy.
¹⁰ Department of Obstetrics and Gynecology, Ziekenhuisgroep Twente (Hospital Group Twente), Post Box 7600, 7600 SZ Almelo, the Netherlands.
¹¹ Department Gynaecology, King's College Hospital, Denmark Hill, London SE5 9RS, UK.
¹² Menopause Health Clinic, Dublin, Ireland.
¹³ Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
¹⁴ Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland.
¹⁵ Department of Obstetrics and Gynecology, University of Granada, Spain.
¹⁶ Department of Women's Health, University Hospital Tuebingen, Germany; Beijing OB/GYN Hospital, Capital Medical University, China.
¹⁷ Department of Gynecological Endocrinology, National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of the Russian Federation, Moscow, Russia.
¹⁸ Department of Obstetrics and Gynecology, University Clinic Inselspital, Bern, Switzerland.
¹⁹ Department of Obstetrics and Gynecology, University Hospital St. Poelten-Lilienfeld, Austria.
²⁰ Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.

PMID: 35569270
DOI: 10.1016/j.maturitas.2022.04.008

Abstract

This care pathway from the European Menopause and Andropause Society (EMAS) provides an updated pathway for monitoring and guidance of women at midlife, focusing on those approaching the end of the reproductive life-cycle, going through the menopausal transition and beyond. The care pathway is written by professionals involved in women's health and provides a stepwise individualized approach, stratified according to needs, symptoms and reproductive stage. Furthermore, the pathway provides details on screening for chronic diseases related to menopause and ageing. Treatment options for climacteric symptoms range from menopausal hormone therapy to non-hormonal alternatives and lifestyle modifications. Therapy should be tailored to personal needs and wishes. The pathway aims to offer a holistic, balanced approach for monitoring middle-aged women, aiming to control health problems effectively and ensure healthy ageing.

Keywords: Breast cancer; Cardiovascular disease; Climacteric; Hormone replacement therapy; Hot flushes; Menopause; Night sweats; Osteoporosis; Women.

PubMed Disclaimer

Conflict of interest statement

1. Irene Lambrinoudaki: None declared. 2.Eleni Armeni: None declared. 3. Dimitrios G. Goulis: None declared. 4. Silvia Bretz: None declared. 5. Iuliana Ceausu: None declared. 6. Fatih Durmusoglu: None declared. 7. Risto Erkkola: None declared. 8. Ivan Fistonic: has received consulting fees in the past 3 years from Fotona Inc. 9. Marco Gambacciani: has received speaker and consulting fees in the past 3 years from MSD, Theramex and Bayer. 10. Marije Geukes: None declared. 11. Haitham Hamoda: None declared. 12. Caiomhe Hartley: None declared. 13. Angelica Lindén Hirschberg in the past 3 years has received grant support from ITF Research Pharma for the “Blissafe” study.

Comment in

HRT in a new light: Thanks UK.
Gambacciani M, Cagnacci A. Gambacciani M, et al. Maturitas. 2022 Oct;164:98-99. doi: 10.1016/j.maturitas.2022.08.004. Epub 2022 Aug 19. Maturitas. 2022. PMID: 36027841 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

Affiliations

Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

Authors

Affiliations

Abstract

Conflict of interest statement

Comment in

MeSH terms

LinkOut - more resources

Full Text Sources